These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11214615)

  • 1. Usefulness of PCR in situ hybridization as a technique for morphological detection of human papillomavirus in uterine cervical neoplasia.
    Oguchi T; Sato S; Xiao YH; Yokoyama Y; Saito Y
    Eur J Gynaecol Oncol; 2000; 21(6):585-7. PubMed ID: 11214615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.
    Guo M; Gong Y; Deavers M; Silva EG; Jan YJ; Cogdell DE; Luthra R; Lin E; Lai HC; Zhang W; Sneige N
    J Clin Microbiol; 2008 Jan; 46(1):274-80. PubMed ID: 17977987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection.
    Kelesidis T; Aish L; Steller MA; Aish IS; Shen J; Foukas P; Panayiotides J; Petrikkos G; Karakitsos P; Tsiodras S
    Am J Clin Pathol; 2011 Jul; 136(1):119-27. PubMed ID: 21685039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization.
    Sheng Z; Minato H; Sasagawa T; Nakada S; Kinoshita E; Kurose N; Nojima T; Makinoda S
    Int J Clin Exp Pathol; 2013; 6(10):2168-77. PubMed ID: 24133595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of light microscopy, in situ hybridization and polymerase chain reaction for detection of human papillomavirus in histological tissue of cervical intraepithelial neoplasia.
    Lie AK; Skjeldestad FE; Hagen B; Johannessen E; Skarsvåg S; Haugen OA
    APMIS; 1997 Feb; 105(2):115-20. PubMed ID: 9113073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
    Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
    Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions.
    Birner P; Bachtiary B; Dreier B; Schindl M; Joura EA; Breitenecker G; Oberhuber G
    Mod Pathol; 2001 Jul; 14(7):702-9. PubMed ID: 11455003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human papillomavirus on Papanicolaou-stained cervical smears using indirect in situ polymerase chain reaction hybridization.
    Manavi M; Bauer M; Pischinger K; Czerwenka K
    Arch Pathol Lab Med; 2001 Mar; 125(3):353-7. PubMed ID: 11231482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV.
    Qureshi MN; Rudelli RD; Tubbs RR; Biscotti CV; Layfield LJ
    Diagn Cytopathol; 2003 Sep; 29(3):149-55. PubMed ID: 12951683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human papillomavirus in cervical intra-epithelial neoplasia, using in situ hybridization and various polymerase chain reaction techniques.
    Zehbe I; Rylander E; Edlund K; Wadell G; Wilander E
    Virchows Arch; 1996 Jun; 428(3):151-7. PubMed ID: 8688969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful application of indirect in-situ polymerase chain reaction to tissues fixed in Bouin's solution.
    Li Vigni R; Bianchi UA; Carosi G; Lomini M; Falchetti M; Callea F; Pecorelli S
    Histopathology; 1999 Aug; 35(2):134-43. PubMed ID: 10460658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive HPV in-situ hybridization (ISH) assay as an aid in the diagnosis of cervical intraepithelial neoplasia in cervical tissue specimens: an analytical and functional characterization.
    Zhang W; Kapadia M; Sugarman M; Free H; Upchurch C; Gniewek R; White K; Miller M; Vladich F; Ferenczy A; Wright TC; Stoler MH; Pestic-Dragovich L
    Int J Gynecol Pathol; 2012 Nov; 31(6):588-95. PubMed ID: 23018222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of human papillomavirus types in low and high grade cervical squamous neoplasia by in situ hybridization.
    Southern SA; Graham DA; Herrington CS
    Diagn Mol Pathol; 1998 Apr; 7(2):114-21. PubMed ID: 9785011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
    Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
    Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colourimetric signal amplification of in situ hybridization assay for human papillomavirus DNA detection in cytological samples.
    Vocaturo A; Marandino E; Celata E; Caffo A; Moauro M; Vocaturo G; Perrone Donnorso R
    J Exp Clin Cancer Res; 2002 Jun; 21(2):239-46. PubMed ID: 12148585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of fluorescence in situ hybridization and hybrid capture 2 analyses of cervical cytology specimens diagnosed as low grade squamous intraepithelial lesion for the detection of high grade cervical intraepithelial neoplasia.
    Voss JS; Kipp BR; Campion MB; Sokolova IA; Henry MR; Halling KC; Clayton AC
    Anal Quant Cytol Histol; 2010 Jun; 32(3):121-30. PubMed ID: 20701064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples.
    Hesselink AT; van den Brule AJ; Brink AA; Berkhof J; van Kemenade FJ; Verheijen RH; Snijders PJ
    Cancer; 2004 Feb; 102(1):11-8. PubMed ID: 14968413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.